US 'not targeting' India, says FDA chief
WASHINGTON (AFP) - US regulators are not targeting India, despite a series of import restrictions on drugs from the major US trading partner, the head of the US Food and Drug Administration said Friday.
FDA Commissioner Margaret Hamburg briefed reporters after her first official trip to India, where she met with government and industry leaders earlier this month.
India is the second largest US supplier of prescription and over-the-counter drugs, and its big pharma companies Ranbaxy and Wockhardt have faced a series of US import restrictions over safety concerns.
"We are not targeting Indian countries. We are undertaking our required regulatory activities," Ms Hamburg said.